Lung Ultrasound to Diagnose COVID-19

Completed

• Conditions: Respiratory Complication; Lung Ultrasound; Covid-19

• Registration Number: NCT04368338
• Lead Sponsor: Centre Hospitalier Universitaire, Amiens

Brief Summary

Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-28
• Study First Submitted: 2020-04-28
• Study First Submitted QC: 2020-04-28
• Study First Posted: 2020-04-29
• Primary Completion: 2021-01-28
• Status Verified: 2021-07
• Study Completion: 2021-07-20
• Last Update Submitted: 2021-07-20
• Last Update Posted: 2021-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• patients admitted to Emergency Room for suspicion of COVID-19 infection with has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound

Exclusion Criteria

• patients < 18 years of age or under guardianship or curators,
• pregnancy
• poor echogenicity due to the presence of an acoustic barrier (pneumothorax, subcutaneous emphysema, etc.)
• patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory distress syndrome (ARDS))
• chronic interstitial lung disease
• patients who will refuse to give their consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Lung ultrasound/biological correlation research modulating the severity of Covid-19 disease	6 months	Polymerase chain reaction tests after reverse transcription for the detection of covid-19 viral RNA will be done as biological test.

Trial Locations

Locations (1)

BAR; 🇫🇷 Amiens, France